Anger, hope from families and survivors of opioid crisis

Families torn apart by opioid addiction are reacting with anger and hope to news of a multimillion-dollar settlement reached by the maker of OxyContin and the state of Oklahoma.

Oklahoma officials announced Tuesday the details of a $270 million deal with Purdue Pharma. Numerous lawsuits accuse the company of minimizing the addiction risk and pushing doctors to up dosages even as overdoses climbed.

The settlement comes two months before the Oklahoma case was set for trial.

The agreement angers some families who say a trial is the best way to hold the drug company responsible. Others see hope that much of the money will go toward a National Center for Addiction Studies and Treatment at Oklahoma State University in Tulsa.

The remaining defendants are still facing trial May 28.